Inventor · disambiguated record
H. Ralph Snodgrass
Also filed as: SNODGRASS H R · SNODGRASS H RALPH · SNODGRASS RALPH H
23 granted patents·10 pending applications·214 citations·filing 1994–2024
95Inventor score
Files withPROGENITOR INC10VISTAGEN THERAPEUTICS INC7INDEVUS PHARMACEUTICALS INC5VISTAGEN THERAPUETICS INC3SNODGRASS H RALPH2
Top patents by PatentIndex Score
33 records- 0189US5643748AHU-B1.219, a novel human hematopoietin receptorPROGENITOR INC·Filed 1994·Granted Jul 1, 1997·54 cites·14 claims
- 0286US8143009B2Toxicity typing using liver stem cellsSNODGRASS H RALPH·Filed 2006·Granted Mar 27, 2012·6 cites·27 claims
- 0385US2025161251A1Dosage forms and therapeutic uses of l-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0479US12036198B2Dosage forms and therapeutic uses of L-4-chlorokynurenineVISTAGEN THERAPUETICS INC·Filed 2022·Granted Jul 16, 2024·0 cites·18 claims
- 0573US2024122887A1Therapeutic uses of l-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0671US10632091B2Dosage forms and therapeutic uses of L-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2018·Granted Apr 28, 2020·0 cites·6 claims
- 0770US10617663B2Dosage forms and therapeutic uses of L-4-chlorokynurenineVISTAGEN THERAPUETICS INC·Filed 2018·Granted Apr 14, 2020·0 cites·9 claims
- 0870US9993450B2Dosage forms and therapeutic uses of L-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2014·Granted Jun 12, 2018·0 cites·3 claims
- 0970US5763211AIsolated nucleic acid encoding Hu-B1.219, a novel human hematopoietinPROGENITOR INC·Filed 1994·Granted Jun 9, 1998·23 cites·54 claims
- 1069US5869610AHu-B1.219, a novel human hematopoietin receptorPROGENITOR INC·Filed 1996·Granted Feb 9, 1999·18 cites·39 claims
- 1166US6005080AAntibodies specific for Hu-B1.219, a novel hematopoietin receptorPROGENITOR INC·Filed 1996·Granted Dec 21, 1999·16 cites·14 claims
- 1265US10980758B2Dosage forms and therapeutic uses of L-4-chlorokynurenineVISTAGEN THERAPUETICS INC·Filed 2018·Granted Apr 20, 2021·0 cites·6 claims
- 1365US5912123ADetection of the leptin receptor in reproductive organs and methods for regulating reproductive biologyPROGENITOR INC·Filed 1996·Granted Jun 15, 1999·15 cites·48 claims
- 1464US9993453B2Dosage forms and therapeutic uses L-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2016·Granted Jun 12, 2018·0 cites·11 claims
- 1564US5856098ADetection of a leptin receptor variantPROGENITOR INC·Filed 1996·Granted Jan 5, 1999·26 cites·19 claims
- 1664US2005158287A1Methods for using the obese gene and its gene product to identify hematopoietic progenitor cellsINDEVUS PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1761US6953670B2Methods for identifying compounds capable of supplementing the biological activity of leptinINDEVUS PHARMACEUTICALS INC·Filed 2002·Granted Oct 11, 2005·0 cites·11 claims
- 1859US6838079B2Methods for using the obese product to stimulate hematopoietic developmentINDEVUS PHARMACEUTICALS INC·Filed 2002·Granted Jan 4, 2005·0 cites·11 claims
- 1959US6355237B1Methods for using the obese gene and its gene product to stimulate hematopoietic developmentPROGENITOR INC·Filed 1996·Granted Mar 12, 2002·10 cites·11 claims
- 2058US5877281ADevelopmentally-regulated endothelial cell locus-1PROGENITOR INC·Filed 1996·Granted Mar 2, 1999·17 cites·53 claims
- 2158US2019321317A1Therapeutic uses of l-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2255US8512957B2Toxicity typing using liver stem cellsSNODGRASS H RALPH·Filed 2012·Granted Aug 20, 2013·0 cites·25 claims
- 2354US2005266486A1Methods for treating obesity by inhibiting expression of obese gene product receptor variantINDEVUS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2452US5882860ADetection of a leptin receptor variant and methods for regulating obesityPROGENITOR INC·Filed 1996·Granted Mar 16, 1999·16 cites·18 claims
- 2551US7041801B1Antibodies binding to polypeptides encoded by developmentally-regulated endothelial cell locus-1VALENTIS INC·Filed 1999·Granted May 9, 2006·6 cites·12 claims
- 2647US2002012905A1Toxicity typing using liver stem cellsFiled 2001·Application pending·0 cites
- 2747US2018140568A1Therapeutic uses of l-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2847US2009280096A1Pancreatic endocrine progenitor cells derived from pluripotent stem cellsKUBO ATSUSHI·Filed 2009·Application pending·0 cites
- 2941US2002045179A1Toxicity typing using mesenchymal stem cellsFiled 2001·Application pending·0 cites
- 3041US2001039006A1Toxicity typing using embryoid bodiesFiled 2001·Application pending·0 cites
- 3138US5874562ANucleic acid encoding developmentally-regulated endothelial cell locus-1PROGENITOR INC·Filed 1995·Granted Feb 23, 1999·7 cites·41 claims
- 3235US6524806B1Methods of screening for ligands of human hemetopoietin receptor HU-B1.219INDEVUS PHARMACEUTICALS INC·Filed 1999·Granted Feb 25, 2003·0 cites·77 claims
- 3332US6451523B1Detection of a leptin receptor variant and methods for regulating obesityINTERNEURON PHARMA·Filed 1996·Granted Sep 17, 2002·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when H. Ralph Snodgrass files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →